REACH

REACH, which stands for the Regulation on Registration, Evaluation, Authorisation, and Restriction of Chemicals, commenced its regulatory role on June 1, 2007. This regulation represents a significant overhaul and enhancement of the previous European Union (EU) legislative framework concerning chemicals.

REACH

REACH: REACH (EC 1907/2006) is underpinned by the overarching objective of fortifying the safeguarding of both human health and the environment by expediting the comprehensive identification of inherent attributes of chemical substances. This multifaceted endeavour is achieved through the four pivotal processes of REACH, encompassing the registration, evaluation, authorization, and restriction of chemicals. Moreover, REACH strives to cultivate innovation and bolster the competitive edge of the EU chemicals industry.

 

At the core of the REACH Regulation lies the principle of "No data, no market." This fundamental tenet places the onus squarely on industry stakeholders to adeptly manage the risks posed by chemicals and provide essential safety data on these substances. Manufacturers and importers bear the responsibility of acquiring comprehensive information on the properties of their chemical substances, ensuring their safe handling, and registering this information within the central database housed within the European Chemicals Agency (ECHA) located in Helsinki. ECHA operates as the central nerve center of the REACH system, overseeing the essential databases, coordinating the in-depth assessment of questionable chemicals, and actively constructing a public repository where consumers and professionals can access critical hazard information.

Furthermore, the Regulation advocates for the progressive substitution of the most hazardous chemicals, denoted as “substances of very high concern,” once suitable alternative options are identified.

The driving force behind the development and adoption of the REACH Regulation primarily stems from the realization that a multitude of substances have been manufactured and introduced into the European market for an extended period, often in substantial volumes. Nevertheless, there remains an alarming dearth of pertinent information concerning the risks these substances pose to human health and the environment. Filling these critical information gaps is imperative to empower industries to comprehensively assess the potential hazards and associated risks of these substances, subsequently enabling the implementation of robust risk management measures that safeguard both human well-being and environmental integrity.

wpChatIcon